Psychiatric and neuropsychiatric syndromes and COVID-19
- PMID: 32711699
- PMCID: PMC7377679
- DOI: 10.1016/S2215-0366(20)30291-1
Psychiatric and neuropsychiatric syndromes and COVID-19
Comment on
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
References
-
- Rogers JP, Chesney E, Oliver D. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(20)30203-0. published online May 18. - DOI - PMC - PubMed
-
- Vik-Mo AO, Giil LM, Borda MG, Ballard C, Aarsland D. The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study. Br J Psychiatry. 2020;216:43–48. - PubMed
-
- Ballard C, Orrell M, YongZhong S. Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: a factorial cluster-randomized controlled trial by the Well-Being and Health for People With Dementia (WHELD) program. Am J Psychiatry. 2016;173:252–262. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources